US Stocks Recover as AI Potential Sparks Market Optimism
The U.S. stock market rebounded on Tuesday, October 24, 2023, as investors found renewed optimism in the potential of artificial intelligence (AI) technology. The S&P 500 index rose by 0.6%,…
Breaking News & Top Stories
The U.S. stock market rebounded on Tuesday, October 24, 2023, as investors found renewed optimism in the potential of artificial intelligence (AI) technology. The S&P 500 index rose by 0.6%,…
Bitcoin’s value fell by 2.3% to $68,674.29 on February 16, 2024, marking a decline of 22.58% year-to-date. This drop occurred despite a broader market context, as the S&P 500 and…
On January 22, 2024, Barclays adjusted its price target for Edison International (NYSE:EIX) to $67, down from $68, while reaffirming an Overweight rating on the stock. This change reflects a…
Global stock markets are attempting to regain stability after significant declines on February 3, 2026. Major indices, including the S&P 500, Dow Jones Industrial Average, and Nasdaq Composite, experienced substantial…
Global stock markets experienced a significant upswing on Tuesday, driven by remarkable gains in South Korea and Japan. The South Korean benchmark index surged by nearly 7%, while Japan’s Nikkei…
US stocks rebounded on March 15, 2024, following President Donald Trump’s decision to withdraw threats of tariffs. The S&P 500 index rose by 0.5%, while the Dow Jones Industrial Average…
U.S. futures fell on Monday as Asian markets experienced gains, following news that Federal Reserve Chair Jerome Powell received subpoenas from the Department of Justice. These legal developments relate to…
UPDATE: U.S. stocks surged to record highs today following a mixed jobs report, igniting optimism on Wall Street. The S&P 500 climbed 0.6% to surpass its previous all-time high, while…
UPDATE: U.S. stocks are experiencing a lull in trading this morning, January 7, 2026, as investors await key economic data that could steer market direction. Early trading hours show a…
Investors are weighing the potential of two biotechnology firms, Avidity Biosciences (NASDAQ: RNA) and Galecto (NASDAQ: GLTO), in the evolving landscape of medical research and development. This analysis contrasts the…